Stacey W. Martin

ORCID: 0000-0003-1767-6042
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Bacterial Infections and Vaccines
  • Pneumonia and Respiratory Infections
  • Mosquito-borne diseases and control
  • Viral Infections and Vectors
  • Vaccine Coverage and Hesitancy
  • Bacillus and Francisella bacterial research
  • Influenza Virus Research Studies
  • Infective Endocarditis Diagnosis and Management
  • SARS-CoV-2 and COVID-19 Research
  • Global Maternal and Child Health
  • COVID-19 epidemiological studies
  • Animal Disease Management and Epidemiology
  • Vector-Borne Animal Diseases
  • Respiratory viral infections research
  • Forest ecology and management
  • Malaria Research and Control
  • Virology and Viral Diseases
  • Infectious Encephalopathies and Encephalitis
  • Vector-borne infectious diseases
  • Public Health Policies and Education
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Viral Infections and Outbreaks Research
  • Diphtheria, Corynebacterium, and Tetanus
  • Forest Biomass Utilization and Management
  • COVID-19 Impact on Reproduction

Centers for Disease Control and Prevention
2015-2025

University of Rhode Island
2024

National Center for Emerging and Zoonotic Infectious Diseases
2017-2023

Center for Surveillance, Epidemiology, and Laboratory Services
2016-2022

National Center on Birth Defects and Developmental Disabilities
2021

National Institute for Occupational Safety and Health
2021

Epidemic Intelligence Service
2016-2021

Computer Emergency Response Team
2021

AID Atlanta
2016-2021

National Center for Chronic Disease Prevention and Health Promotion
2021

Many pregnant persons in the United States are receiving messenger RNA (mRNA) coronavirus disease 2019 (Covid-19) vaccines, but data limited on their safety pregnancy.From December 14, 2020, to February 28, 2021, we used from "v-safe after vaccination health checker" surveillance system, v-safe pregnancy registry, and Vaccine Adverse Event Reporting System (VAERS) characterize initial of mRNA Covid-19 vaccines persons.A total 35,691 participants 16 54 years age identified as pregnant....

10.1056/nejmoa2104983 article EN New England Journal of Medicine 2021-04-21

As of April 30, 2021, approximately 101 million people in the U.S. had been fully vaccinated against COVID-19. Almost 10,300 COVID-19 vaccine breakthrough infections were reported from 46 states and territories. Vaccine occur only a small fraction all people.

10.15585/mmwr.mm7021e3 article EN MMWR Morbidity and Mortality Weekly Report 2021-05-25

death, life-threatening illness, hospitalization or prolongation of hospitalization, permanent disability, congenital anomaly, birth defect.https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr

10.15585/mmwr.mm7008e3 article EN MMWR Morbidity and Mortality Weekly Report 2021-02-19
Megan R. Reynolds Abbey M. Jones Emily E. Petersen Ellen H. Lee Marion E. Rice and 95 more Andrea Bingham Sascha Ellington Nicole Evert Sarah Reagan-Steiner Titilope Oduyebo Catherine Brown Stacey W. Martin Nina Ahmad Julu Bhatnagar Jennifer Macdonald Carolyn Gould Anne D. Fine Kara D. Polen Heather Lake‐Burger Christina Hillard Noémi B. Hall Mahsa M. Yazdy Karnesha Slaughter Jamie N. Sommer Alys Adamski Meghan Raycraft Shannon Fleck‐Derderian Jyoti Gupta Kimberly Newsome Madelyn A. Baez-Santiago Sally Slavinski Jennifer White Cynthia A. Moore Carrie K. Shapiro‐Mendoza Lyle R. Petersen Coleen Boyle Denise J. Jamieson Dana Meaney‐Delman Margaret A. Honein Jennifer Keys Adair Irene Ruberto Dirk Haselow Lucille K. Im Wendy Jilek Monica S. Lehmann Richard S. Olney Charsey Cole Porse Karen C. Ramstrom Similoluwa Sowunmi Natalie S. Marzec K. Justin Davis Andrea Morrison M. Zachariah Fraser Colleen Ann O'Connor Wendy Chung Folasuyi Richardson Taylor Sexton Meredith E. Stocks Senait Woldai Amanda Marie Bundek Jennifer L. Zambri Cynthia C. Goldberg Leah Eisenstein Jennifer Jackson Russell Kopit Teresa C. Logue Raphael Mendoza Amanda Feldpausch Teri Graham Sylvia Mann Sarah Y. Park Kris K. Carter Emily Potts Taryn Stevens Sean Simonson Julius Tonzel Shari Davis Sara Robinson Judie Hyun Erin Jenkins Monika Piccardi Lawrence D. Reid Julie E. Dunn Cathleen A. Higgins Angela E. Lin Gerlinde S. Munshi Kayleigh Sandhu Sarah Scotland Susan Soliva Glenn Copeland Kimberly Signs Elizabeth Schiffman Paul Byers Sheryl Hand Christine L. Mulgrew Jeff Hamik Samir Koirala Lisa Ludwig Carolyn Fredette Kristin Garafalo

In collaboration with state, tribal, local, and territorial health departments, CDC established the U.S. Zika Pregnancy Registry (USZPR) in early 2016 to monitor pregnant women laboratory evidence of possible recent virus infection their infants.This report includes an analysis completed pregnancies (which include live births pregnancy losses, regardless gestational age) 50 states District Columbia (DC) reported USZPR from January 15 December 27, 2016. Birth defects potentially associated...

10.15585/mmwr.mm6613e1 article EN MMWR Morbidity and Mortality Weekly Report 2017-04-04

Pregnant women living in or traveling to areas with local mosquito-borne Zika virus transmission are at risk for infection, which can lead severe fetal and infant brain abnormalities microcephaly (1). In February 2016, CDC recommended 1) routine testing infection of asymptomatic pregnant ongoing the first prenatal care visit, 2) retesting during second trimester who initially test negative, 3) signs symptoms consistent disease (e.g., fever, rash, arthralgia, conjunctivitis) any time...

10.15585/mmwr.mm6623e1 article EN MMWR Morbidity and Mortality Weekly Report 2017-06-08

A POORLY controlled vaccine-preventable disease in the United States, despite a well-established childhood vaccination program and high coverage. 1Although infants have substantially higher rates of pertussis compared with other age groups, data from National Notifiable Diseases Surveillance System reflect recent increase number reported cases among children aged 7 to 10 years.In 2010, this group had second highest incidence States. 2 The changing epidemiology raises important questions...

10.1001/jama.2012.14939 article EN JAMA 2012-11-27

OBJECTIVE: To assess the risk of pertussis by time since vaccination in children Minnesota and Oregon who received 5 doses acellular vaccines (DTaP). METHODS: These cohort analyses included born between 1998 2003 had DTaP recorded state Immunization Information Systems. records statewide surveillance data were combined. Incidence rates ratios for calculated 6 years after receipt fifth dose. RESULTS: The cohorts 224 378 179 011 from Oregon; 458 89 cases identified Oregon, respectively....

10.1542/peds.2012-1928 article EN PEDIATRICS 2013-03-12

At its June 2015 meeting, the Advisory Committee on Immunization Practices (ACIP) recommended that adolescents and young adults aged 16–23 years may be vaccinated with a serogroup B meningococcal (MenB) vaccine to provide short-term protection against most strains of disease. This report summarizes deliberations ACIP, rationale for decision, recommendations use MenB vaccines in adults. Two have recently been licensed by Food Drug Administration (FDA) United States approved persons 10–25...

10.15585/mmwr.mm6441a3 article EN MMWR Morbidity and Mortality Weekly Report 2015-10-22

The Summary of Notifiable Infectious Diseases and Conditions-United States, 2014 (hereafter referred to as the summary) contains official statistics, in tabular graphic form, for reported occurrence nationally notifiable infectious diseases conditions United States 2014. Unless otherwise noted, data are final totals June 30, 2015. These statistics collected compiled from reports sent by U.S. state territory, New York City, District Columbia health departments National Surveillance System...

10.15585/mmwr.mm6354a1 article EN MMWR Morbidity and Mortality Weekly Report 2016-10-13

Beginning in late 2023, Oropouche virus was identified as the cause of large outbreaks Amazon regions with known endemic transmission and new areas South America Caribbean. The is spread to humans by infected biting midges some mosquito species. Although infection typically causes a self-limited febrile illness, reports two deaths patients vertical associated adverse pregnancy outcomes have raised concerns about threat this human health. In addition approximately 8,000 locally acquired cases...

10.15585/mmwr.mm7335e1 article EN MMWR Morbidity and Mortality Weekly Report 2024-08-27

BACKGROUND. Since introduction of the heptavalent pneumococcal conjugate vaccine in United States 2000, rates invasive disease have declined. However, national impact on pneumonia and otitis media remains unknown. OBJECTIVES. We compared outpatient visits for children before after introduction. METHODS. Rates ambulatory nonspecific pneumonia, media, other acute respiratory infections were (1994–1999) (2002–2003) using National Ambulatory Medical Care Survey Hospital Survey. To evaluate...

10.1542/peds.2006-0492 article EN PEDIATRICS 2006-09-01

OBJECTIVE. Streptococcus pneumoniae is an important cause of otitis media in children. In this study we estimated the effect routine childhood immunization with heptavalent pneumococcal conjugate vaccine on frequent (3 episodes 6 months or 4 1 year) and pressure-equalizing tube insertions. PATIENTS AND METHODS. The population included all children who were enrolled at birth TennCare selected upstate New York commercial insurance plans as July 1998 continuously followed until 5 years old,...

10.1542/peds.2006-2138 article EN PEDIATRICS 2007-04-01

Background. The conjugate vaccine against serogroup A Neisseria meningitidis (NmA), MenAfriVac, was first introduced in mass vaccination campaigns of 1–29-year-olds Burkina Faso 2010. It is not known whether MenAfriVac has an impact on NmA carriage.

10.1093/cid/cis892 article EN Clinical Infectious Diseases 2012-10-19

An analysis assessing for associations between pertactin production and both clinical presentation vaccine history found a significant association vaccination status, suggesting that vaccinated persons have greater susceptibility to deficient strains compared producing strains.

10.1093/cid/ciu788 article EN public-domain Clinical Infectious Diseases 2014-10-09

Infants aged <1 year are at highest risk for pertussis-related morbidity and mortality. In 2012, Tdap (tetanus toxoid, reduced diphtheria acellular pertussis) vaccine was recommended women during each pregnancy to protect infants in the first months of life; data on effectiveness this strategy currently limited. We conducted a case-control evaluation among pertussis cases <2 old with cough onset between 1 January 2011 31 December 2014 from 6 US Emerging Infection Program Network states....

10.1093/cid/cix724 article EN public-domain Clinical Infectious Diseases 2017-08-11

Background. During 9 May 2010–7 2011, an outbreak of pertussis-like illness (incidence, 80 cases per 100 000 persons) occurred in Franklin County, Ohio. The majority were identified by IS481-directed polymerase chain reaction (PCR), which does not differentiate among Bordetella species. We sought to determine etiology and epidemiologic characteristics. Methods. obtained demographic, clinical, vaccination-related data from the Ohio Disease Reporting System Impact Statewide Immunization...

10.1093/cid/cis888 article EN Clinical Infectious Diseases 2012-10-19

Although cerebrospinal fluid (CSF) culture is the diagnostic reference standard for bacterial meningitis, its sensitivity limited, particularly when antibiotics were previously administered. CSF Gram staining and real-time PCR are theoretically less affected by antibiotics; however, it difficult to evaluate these tests with an imperfect standard. from patients suspected meningitis Salvador, Brazil tested culture, stain, using S. pneumoniae, N. meningitidis, H. influenzae specific primers...

10.1186/1471-2334-13-26 article EN cc-by BMC Infectious Diseases 2013-01-22

BACKGROUND: Pertussis is poorly controlled, with the highest rates of morbidity and mortality among infants. Although source infant pertussis often unknown, when identified, mothers have historically been most common reservoir transmission. Despite high vaccination coverage, disease incidence has increasing. We examined whether infection (SOI) changed in United States light changing epidemiology. METHODS: Cases &amp;lt;1 year old were identified at Enhanced Surveillance sites between January...

10.1542/peds.2015-1120 article EN PEDIATRICS 2015-09-08

† Symptoms of Zika virus disease include acute onset fever, maculopapular rash, arthralgia, or conjunctivitis.§ Persons with ongoing possible exposure those who reside in frequently travel (e.g., daily weekly) to an area risk for transmission.¶ For the purposes this guidance, recent virus/flavivirus infection is defined as a during current pregnancy periconceptional period (i.e., 8 weeks before conception 6 last menstrual period).

10.15585/mmwr.mm6629e1 article EN MMWR Morbidity and Mortality Weekly Report 2017-07-24

CDC has updated its interim guidance for persons with possible Zika virus exposure who are planning to conceive (1) and prevent transmission of through sexual contact (2), now combined into a single document. Guidance care pregnant women was previously published (3). Possible is defined as travel or residence in an area active (http://www.cdc.gov/zika/geo/index.html), sex* without condom† partner traveled lived transmission. Based on new though limited data, recommends that all men...

10.15585/mmwr.mm6539e1 article EN MMWR Morbidity and Mortality Weekly Report 2016-09-30

BACKGROUND: Acellular pertussis vaccines replaced whole-cell for the 5-dose childhood vaccination series in 1997. A sixth dose of pertussis-containing vaccine, tetanus toxoid, reduced diphtheria and acellular pertussis, adsorbed (Tdap), was recommended 2005 adolescents adults. Studies examining Tdap vaccine effectiveness (VE) among who have received all are limited. METHODS: To assess VE duration protection, we conducted a matched case-control study during 2012 epidemic Washington born...

10.1542/peds.2014-3358 article EN PEDIATRICS 2015-05-05
Coming Soon ...